BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
2/27/2024 11:58:45 AM | Browse: 58 | Download: 121
 |
Received |
|
2023-12-06 07:11 |
|
Peer-Review Started |
|
2023-12-06 07:11 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2023-12-20 02:46 |
|
Revised |
|
2023-12-26 17:32 |
|
Second Decision |
|
2024-01-17 02:54 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Company Editor-in-Chief |
|
2024-01-17 08:37 |
|
Articles in Press |
|
2024-01-17 08:37 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2024-02-06 07:15 |
|
Publish the Manuscript Online |
|
2024-02-27 11:58 |
| ISSN |
1948-5182 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Endocrinology & Metabolism |
| Manuscript Type |
Review |
| Article Title |
Metabolic-associated fatty liver disease and sarcopenia: A double whammy
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Aditya Viswanath, Sherouk Fouda, Cornelius James Fernandez and Joseph M Pappachan |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Joseph M Pappachan, FRCP, MD, Academic Editor, N/A, Professor, Department of Endocrinology and Metabolism, Lancashire Teaching Hospitals NHS Trust, Sharoe Green Lane, Preston PR2 9HT, United Kingdom. drpappachan@yahoo.co.in |
| Key Words |
Metabolic-associated fatty liver disease; Sarcopenia; Sarcopenic obesity; Lean metabolic-associated fatty liver disease; Cardiovascular disease; Liver-muscle axis |
| Core Tip |
Metabolic-associated fatty liver disease (MAFLD) is associated with sarcopenia in a significant proportion of individuals. Sarcopenia can be a consequence of the comorbidities associated with MAFLD (such as obesity or adiposity) or a direct result of advanced stages of MAFLD such as fibrosis and cirrhosis. On the other hand, sarcopenia can worsen MAFLD due to reduced exercise capacity and the release of various myokines. Understanding the strong interlink between MAFLD and sarcopenia is important to plan appropriate therapeutic strategies. We discuss the pathobiological aspects of this interlink and the potential clinical and metabolic complications of the coexistence of MAFLD and sarcopenia in this comprehensive clinical update review. |
| Publish Date |
2024-02-27 11:58 |
| Citation |
Viswanath A, Fouda S, Fernandez CJ, Pappachan JM. Metabolic-associated fatty liver disease and sarcopenia: A double whammy. World J Hepatol 2024; 16(2): 152-163 |
| URL |
https://www.wjgnet.com/1948-5182/full/v16/i2/152.htm |
| DOI |
https://dx.doi.org/10.4254/wjh.v16.i2.152 |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
